CAD4COVID-XRay and CAD4COVID-CT are CE certified
Today, June 10th 2020, our Notified Body has granted CE certifications for both our CAD4COVID-CT and CAD4COVID-XRay solutions. Both have been granted Class II CE certifications, meaning they can officially be used as tools to aid in the interpretation of imaging COVID-19. The CE (0344) approval will help to further support the roll-out of both solutions, which will continue to be available free-of-charge to support healthcare facilities globally to face the pandemic.
LungQ is cleared for clinical use in South Korea
Our chest CT analysis product LungQ is now cleared for clinical use in South Korea. We look forward to working with our South Korean users on quantitative analysis of their chest CT scans.
We have launched CAD4COVID-CT
Today, we are proud to launch CAD4COVID-CT, our artificial intelligence software for the analysis of COVID-19 on CT scans. Three weeks ago, we already launched our X-ray based solution for COVID-19 (CAD4COVID-Xray) in collaboration with Delft Imaging, which has since been made accessible to healthcare facilities in twelve countries. Click to read more and visit https://thirona.eu/cad4covid/ or email info@thirona.eu.
Triage for COVID-19 Using AI on Chest X-rays
Thirona is specialized in tuberculosis (TB) screening and with its proven CAD4TB solution has screened over 6 million people in 40 countries. We optimised CAD4TB to triage COVID-19 suspects and are launching this solution free-of-charge.
Thirona is present at the Saudi Opthalmology Symposium
We are present at the Saudi Opthalmology conference held from 12-14 March in the Hilton Ryadh Hotel. Come by to meet us and learn more about our Retina solution RetCAD.
Happy birthday to us!
Thirona became 6 years old today, so it was time to celebrate with some cake.
EFRO subsidy to Thirona, RadboudUMC en Quirem
Thirona is in a collaboration with the RadboudUMC and Quirem in the project Radiology of the Future, sponsored by the EFRO (this article is only in Dutch).
Our LungQ software picks up progression in emphysema and air trapping
A study recently published in Radiology shows Thirona's lung quantification software picks up progression in emphysema and air trapping over 5 years in smokers with and without COPD.
Thirona is present at the TECH020 fair
On February 20th, Thirona will be present at the TECH020 CareerFair for Data Science & AI presented by ADS. Come by to meet us, know more about the company and our vacancies.
RetCAD validation and approval
RetCAD is validated in a scientific study and is also approved for clinical use in Singapore.
In silico heaven
In modern medicine it is more and more important that your clinical trial works and if a device is being implanted it will not be rejected by the body. For this, extensive testing is necessary, however, with the help of computer chips fewer animals and people are needed. In the following article by Gemma Church, this is discussed and RetCAD is also mentioned.
Thirona starts a collaboration with UKE
Thirona will start a pilot study in collaboration with Dr. Toam Katz from the Medical Center Hamburg-Essendorf (UKE). In this study, fundus images will be evaluated by experts from UKE and by the RetCAD software from Thirona. The results of both will be compared to each other.
Rudolfs presented at the COPDGene 2019 fall meeting in Boston
Last week, Rudolfs Latisenko, data scientist at Thirona, presented our deep learning approach for reducing dose-related noise on low dose CT at the COPDGene 2019 fall meeting in Boston. This model was developed in collaboration with Stephen Humphries and David Lynch from National Jewish Health.
Thirona in de Gelderlander
Local newspaper "de Gelderlander" visited Thirona to talk about our research collaboration with ThiraLab. This resulted in the following article (the article is in Dutch).